JP2002542248A5 - - Google Patents

Download PDF

Info

Publication number
JP2002542248A5
JP2002542248A5 JP2000612301A JP2000612301A JP2002542248A5 JP 2002542248 A5 JP2002542248 A5 JP 2002542248A5 JP 2000612301 A JP2000612301 A JP 2000612301A JP 2000612301 A JP2000612301 A JP 2000612301A JP 2002542248 A5 JP2002542248 A5 JP 2002542248A5
Authority
JP
Japan
Prior art keywords
pharmaceuticals
prevention
treatment
acceptable salt
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000612301A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002542248A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2000/003388 external-priority patent/WO2000063211A1/en
Publication of JP2002542248A publication Critical patent/JP2002542248A/ja
Publication of JP2002542248A5 publication Critical patent/JP2002542248A5/ja
Withdrawn legal-status Critical Current

Links

JP2000612301A 1999-04-17 2000-04-14 ハロアルコキシイミダゾナフチリジン Withdrawn JP2002542248A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99107688.6 1999-04-17
EP99107688 1999-04-17
PCT/EP2000/003388 WO2000063211A1 (en) 1999-04-17 2000-04-14 Haloalkoxy imidazonaphthyridines

Publications (2)

Publication Number Publication Date
JP2002542248A JP2002542248A (ja) 2002-12-10
JP2002542248A5 true JP2002542248A5 (https=) 2007-05-10

Family

ID=8237986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000612301A Withdrawn JP2002542248A (ja) 1999-04-17 2000-04-14 ハロアルコキシイミダゾナフチリジン

Country Status (12)

Country Link
US (1) US6503923B1 (https=)
EP (1) EP1173439B1 (https=)
JP (1) JP2002542248A (https=)
AT (1) ATE240956T1 (https=)
AU (1) AU3966600A (https=)
CA (1) CA2370231A1 (https=)
DE (1) DE60002855T2 (https=)
DK (1) DK1173439T3 (https=)
ES (1) ES2199810T3 (https=)
PT (1) PT1173439E (https=)
SI (1) SI1173439T1 (https=)
WO (1) WO2000063211A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL360412A1 (en) 2000-10-25 2004-09-06 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
EP1370261A2 (en) * 2001-03-08 2003-12-17 AstraZeneca AB New use
US6927292B2 (en) 2001-08-02 2005-08-09 Altana Pharma Ag Tricyclic epoxides
WO2003014120A1 (en) * 2001-08-03 2003-02-20 Altana Pharma Ag Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
NZ531433A (en) * 2001-08-03 2005-09-30 Altana Pharma Ag Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
HRP20040834A2 (en) 2002-02-15 2005-06-30 Altana Pharma Ag Tricyclic n-acyl compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CA2506027A1 (en) 2002-11-19 2004-06-03 Altana Pharma Ag 8-substituted imidazopyridines
BRPI0407541A (pt) * 2003-02-17 2006-02-14 Altana Pharma Ag combinações e uso de compostos farmaceuticamente ativos selecionados
PT1606261E (pt) 2003-03-10 2010-01-11 Nycomed Gmbh Novo processo para a preparação de roflumilast
JP2006528231A (ja) * 2003-05-27 2006-12-14 アルタナ ファルマ アクチエンゲゼルシャフト プロトンポンプ阻害剤と胃腸運動性を変更する化合物との医薬品組合せ物
EP1682133A1 (en) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
EP1697358A1 (en) 2003-12-19 2006-09-06 Altana Pharma AG Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
NZ549011A (en) * 2004-02-17 2009-04-30 Altana Pharma Ag Tricyclic imidazopyridines and intermediates for the synthesis thereof
US7931659B2 (en) * 2004-09-10 2011-04-26 Penumbra, Inc. System and method for treating ischemic stroke
WO2006037748A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
IL108520A (en) 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0971922B1 (en) * 1997-03-24 2004-04-28 ALTANA Pharma AG Tetrahydropyrido compounds
EE04677B1 (et) 1998-09-23 2006-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahdropridoeetrid, nende kasutamine ja ravim

Similar Documents

Publication Publication Date Title
JP2002542248A5 (https=)
USD449939S1 (en) Bed
USD470329S1 (en) Bed
NO2020019I1 (no) Maraviroc eventuelt i form av et farmasøytisk akseptabelt salt
USD471628S1 (en) Medical vial
NO2020007I1 (no) Sitagliptin, eventuelt i form av et farmasøytisk akseptabelt salt
JP2003503454A5 (https=)
NO2017047I1 (no) Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt
NO2012009I1 (no) Kombinasjonsprodukt av saxaglipin og metformin og farmasøytisk akseptable salter frav, herunder HCI saltene av saxaglipin og metformin
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
NO2013004I1 (no) axitinib, valgfritt i form av et farmasøytisk aksentabelt salt
WO2006102446A3 (en) Multi-particulate, modified-released colonic composition
ATE486840T1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
HRP20010632A2 (en) Matrix tablet enabling prolonged release of gliclazide after administration by the oral route
JP2005507892A5 (https=)
JP2003526626A5 (https=)
IL152479A0 (en) Pharmaceutical form of administration for peptides, methods for its production and use
HRP20050371A2 (en) Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
JP2005509503A5 (https=)
JP2001513504A5 (https=)
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
USD657863S1 (en) Mask
USD529741S1 (en) Towel ring
PT1131297E (pt) Certas caprolactamas substituidas composicoes farmaceuticas contendo-as e sua utilizacao no tratamento de tumores
USD455284S1 (en) Bed